News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Biosearch Technologies and Intelligent Intelligent Medical Devices Finalize cGMP Oligo Supply and Licensing Agreements for IVD Products


3/15/2011 10:24:27 AM

NOVATO, CA and CAMBRIDGE, MA (Monday, March 14, 2011) – Biosearch Technologies, Inc. (Biosearch), a leading supplier of sophisticated oligonucleotide components to the rapidly growing molecular diagnostics industry, and IMDx (privately held), a developer and manufacturer of molecular tests, today announced that Biosearch has licensed access to the BHQ®, CAL Fluor® and Quasar® patents to IMDx. In addition, Biosearch will manufacture cGMP oligonucleotides for IMDx for use in human in-vitro diagnostics.

“Biosearch Technologies is honored to have been chosen as IMDx’s cGMP oligo provider,” says Marc Beal, Director of Corporate Development at Biosearch Technologies. “IMDx assays, powered by BHQ probing technologies, provide a potent combination for future diagnostic tests.”

“We are very pleased to be working with Biosearch. We believe BHQ probes are very effective, leading to highly differentiated products for many markets,” says Alice Jacobs, MD, Chairman & CEO of IMDx.

About Biosearch Technologies, Inc.

Biosearch Technologies, Inc. is a privately held, ISO 9001:2008 certified company, located in northern California. Founded in 1993, Biosearch is a leader in the design, development and manufacture of sophisticated oligonucleotide-based tools. Products include fluorophores (CAL Fluor®, Quasar® and Pulsar® dyes) and dark quenchers (Black Hole Quencher® dyes) to be included in custom-synthesized probe formats for real-time, quantitative PCR and other genomic-based applications.

In addition to basic R&D applications, Biosearch now leverages its demonstrated expertise in fully assembled RUO kits and the cGMP manufacture of oligonucleotide components for molecular diagnostic assays. Biosearch Technologies is registered with the FDA (registration number 3003009025), and as such, its contract manufacturing processes conform to all applicable GMP requirements per 21 CFR Part 820. Biosearch markets include pharmaceutical, in-vitro diagnostic, biotech, ag/bio, environmental and food testing, public health, and biodefense sectors.

For additional information about Biosearch Technologies, Inc., contact info@biosearchtech.com or visit www.biosearchtech.com.

About Intelligent Medical Devices, Inc.

Based in Cambridge, MA. IMDx (www.IntelligentMDx.com) is an innovative company that designs, develops and manufactures molecular diagnostic products. IMDx has developed molecular solutions that are clinically impactful and competitively differentiated for a range of disease areas for current and next generation systems, including targets in infectious diseases, oncology and genetics. IMDx’s expertise spans evolutionary biology, bioinformatics, microbiology, chemistry and molecular biology. These capabilities are harnessed by IMDx’s proprietary bioinformatics and product development processes allowing for the rapid design and development of tests to meet clinical needs.

For additional information about IMDx, contact cc@IntelligentMDx.com or visit www.intelligentMDx.com.


Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES